Search Results

There are 16443 results for: content related to: Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual

  1. You have full text access to this OnlineOpen article
    Near real-time vaccine safety surveillance using electronic health records—a systematic review of the application of statistical methods

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 3, March 2016, Pages: 225–237, Andreia Leite, Nick J. Andrews and Sara L. Thomas

    Version of Record online : 28 JAN 2016, DOI: 10.1002/pds.3966

  2. Near real-time vaccine safety surveillance with partially accrued data

    Pharmacoepidemiology and Drug Safety

    Volume 20, Issue 6, June 2011, Pages: 583–590, Sharon K. Greene, Martin Kulldorff, Ruihua Yin, W. Katherine Yih, Tracy A. Lieu, Eric S. Weintraub and Grace M. Lee

    Version of Record online : 29 APR 2011, DOI: 10.1002/pds.2133

  3. Absence of associations between influenza vaccines and increased risks of seizures, Guillain–Barré syndrome, encephalitis, or anaphylaxis in the 2012–2013 season

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 5, May 2014, Pages: 548–553, Alison Tse Kawai, Lingling Li, Martin Kulldorff, Claudia Vellozzi, Eric Weintraub, Roger Baxter, Edward A. Belongia, Matthew F. Daley, Steven J. Jacobsen, Allison Naleway, James D. Nordin and Grace M. Lee

    Version of Record online : 4 FEB 2014, DOI: 10.1002/pds.3575

  4. Bioavailability of divalproex extended-release formulation relative to the divalproex delayed-release formulation

    Biopharmaceutics & Drug Disposition

    Volume 25, Issue 8, November 2004, Pages: 345–352, Sandeep Dutta and Yiming Zhang

    Version of Record online : 17 SEP 2004, DOI: 10.1002/bdd.420

  5. Extended-Release Divalproex Sodium for Mood Stabilization

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 24, Issue 9, September 2004, Pages: 1147–1153, Dr. Steven C. Stoner, Dr. Beth M. Dubisar, Dr. Jessica W. Lea, Dr. Patricia A. Marken, Mr Leonard V. Ramlatchman and Dr. James B. Reynolds

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.24.13.1147.38088

  6. Comparison of the bioavailability of 250 and 500 mg divalproex sodium extended-release tablets in healthy volunteers

    Biopharmaceutics & Drug Disposition

    Volume 25, Issue 8, November 2004, Pages: 353–357, Sandeep Dutta, Yiming Zhang, Lillian L. Lee and Robert O'Dea

    Version of Record online : 17 SEP 2004, DOI: 10.1002/bdd.421

  7. Naturalistic experience with the use of divalproex sodium on an in-patient unit for adolescent psychiatric patients

    Acta Psychiatrica Scandinavica

    Volume 97, Issue 3, March 1998, Pages: 236–240, J. A. Deltito, J. Levitan, J. Damore, F. Hajal and M. Zambenedetti

    Version of Record online : 13 NOV 2007, DOI: 10.1111/j.1600-0447.1998.tb09994.x

  8. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013–2014 and 2014–2015 seasons

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 8, August 2016, Pages: 928–934, Rongxia Li, Brock Stewart, Michael M. McNeil, Jonathan Duffy, Jennifer Nelson, Alison Tse Kawai, Roger Baxter, Edward A. Belongia and Eric Weintraub

    Version of Record online : 1 APR 2016, DOI: 10.1002/pds.3996

  9. Pediatric post-marketing safety systems in North America: assessment of the current status

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 8, August 2015, Pages: 785–792, Ann W. McMahon, Gerold T. Wharton, Renan Bonnel, Mary DeCelle, Kimberley Swank, Daniela Testoni, Judith U. Cope, Phillip Brian Smith, Eileen Wu and Mary Dianne Murphy

    Version of Record online : 22 JUN 2015, DOI: 10.1002/pds.3813

    Corrected by:

    Erratum: Erratum: Pediatric post-marketing safety systems in North America: assessment of the current status

    Vol. 25, Issue 1, 110–111, Version of Record online: 8 JAN 2016

  10. Mood Stabilizers

    Psychiatry, Third Edition

    David J. Muzina, David E. Kemp, Joseph R. Calabrese, Pages: 2202–2222, 2008

    Published Online : 8 AUG 2008, DOI: 10.1002/9780470515167.ch103

  11. You have full text access to this OnlineOpen article
    Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD)

    Pharmacoepidemiology and Drug Safety

    Volume 26, Issue 4, April 2017, Pages: 437–445, Andreia Leite, Nick J. Andrews and Sara L. Thomas

    Version of Record online : 3 FEB 2017, DOI: 10.1002/pds.4173

  12. You have full text access to this OnlineOpen article
    Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 5, May 2016, Pages: 481–492, Weiling Katherine Yih, Martin Kulldorff, Sukhminder K. Sandhu, Lauren Zichittella, Judith C. Maro, David V. Cole, Robert Jin, Alison Tse Kawai, Meghan A. Baker, Chunfu Liu, Cheryl N. McMahill-Walraven, Mano S. Selvan, Richard Platt, Michael D. Nguyen and Grace M. Lee

    Version of Record online : 17 NOV 2015, DOI: 10.1002/pds.3908

  13. You have free access to this content
    Abstracts

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue S1, September 2015, Pages: 1–587,

    Version of Record online : 25 SEP 2015, DOI: 10.1002/pds.3838

  14. Sequential Statistical Methods for Prospective Postmarketing Safety Surveillance

    Pharmacoepidemiology, Fifth Edition

    Brian L. Strom, Stephen E. Kimmel, Sean Hennessy, Pages: 852–867, 2012

    Published Online : 3 JAN 2012, DOI: 10.1002/9781119959946.ch46

  15. Acute Seizures in a Patient Receiving Divalproex Sodium After Starting Ertapenem Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 27, Issue 8, August 2007, Pages: 1202–1205, Jesse L. Lunde, Robert E. Nelson and Harrison F. Storandt

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.27.8.1202

  16. Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 8, August 2014, Pages: 839–848, Judith C. Maro, Jeffrey S. Brown, Gerald J. Dal Pan and Martin Kulldorff

    Version of Record online : 3 APR 2014, DOI: 10.1002/pds.3618

  17. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder

    Human Psychopharmacology: Clinical and Experimental

    Volume 22, Issue 7, October 2007, Pages: 469–476, Helen R. Winter, C. Lindsay DeVane, Carlos Figueroa, Debra J. Ennis, Jennifer E. Hamer-Maansson, Patty C. Davis and Mark A. Smith

    Version of Record online : 30 AUG 2007, DOI: 10.1002/hup.869

  18. Valproate: Clinical Pharmacological Profile

    Bipolar Psychopharmacotherapy: Caring for the Patient

    Charles L. Bowden, Vivek Singh, Pages: 27–42, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470017953.ch3

  19. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

    Bipolar Disorders

    Volume 11, Issue 3, May 2009, Pages: 225–255, Lakshmi N Yatham, a Sidney H Kennedy, b Ayal Schaffer, b Sagar V Parikh, b Serge Beaulieu, c Claire O'Donovan, d Glenda MacQueen, e Roger S McIntyre, b Verinder Sharma, f Arun Ravindran, b L Trevor Young, a Allan H Young, a Martin Alda, d Roumen Milev, g Eduard Vieta, h Joseph R Calabrese, i Michael Berk, j Kyooseob Ha and k Flávio Kapczinski l

    Version of Record online : 14 APR 2009, DOI: 10.1111/j.1399-5618.2009.00672.x

  20. Safety of Divalproex Sodium in Migraine Prophylaxis: An Open-Label, Long-term Study

    Headache: The Journal of Head and Face Pain

    Volume 39, Issue 9, October 1999, Pages: 633–643, Stephen D. Silberstein, Stephen D. Collins and Long-term Safety of Depakote in Headache Prophylaxis Study Group

    Version of Record online : 17 JUN 2002, DOI: 10.1046/j.1526-4610.1999.3909633.x